ClinicalTrials.gov
public full text
Public Domain
Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"
The purpose of this study is to evaluate the safety in patients with prostate cancer receiving the drug in the routine clinical setting.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer#1173505
- Treatment and monitoring of men with metastatic castration-resistant prostate cancer#185247
- MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy#859880
- Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants#1074924
- Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function.#902216
Record · ID 871457
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive